Main lines of research

  • Erythropoietin as an alternative to transfusion in paediatrics.
  • Clinical application of peritoneal drainage in the treatment of enterocolitis in infants.
  • Chronic functional constipation: treatment with PEG.
  • Creation of a Catalan diagnostic and clinical monitoring network for rare anaemias due to major haemoglobinopathies.
  • Minimal residual disease in risk assessment in the treatment of children with acute lymphoblastic leukaemia in the SHOP protocol (in collaboration with Sant Pau’s Haematology Group).


  • Transplant haematopoietic progenitor cells from alternative donors.
  • Make pre-implant genetic diagnoses.
  • Transplant haematopoietic progenitor cells in congenital immunodeficiencies.
  • Transplant haematopoietic progenitor cells in congenital metabolic pathologies.
  • Research congenital immunodeficiencies.
  • Research Fanconi anaemia.
  • Apply adaptive cell immunotherapy to tumours.
  • Intervention in postasphyxia neuronal damage in infants with asphyxia by applying therapeutic hypothermia.
  • Polytraumatized patient care programme.
  • Implement a multidisciplinary institutional massive transfusion protocol in Sant Pau.

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information